Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 424B4 Offering Prospectus
  10. EFFECT Other Notice of Effectiveness
  11. UPLOAD Other SEC-generated Letter
  12. DEFA14A Proxy Proxy Materials
  13. S-1MEF Other S-1MEF
  14. S-1/A Offering Registration Statement
  15. 8-K Event Other events
  16. PRER14A Other PRER14A
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. S-1/A Offering Registration Statement
  20. 8-K Event Bylaws or fiscal year change

Page 19 of 31 · 604 filings